Direkt zum Inhalt
Merck
Alle Fotos(1)

Key Documents

View All Documentation

K4138

Sigma-Aldrich

Ketaminhydrochlorid/Xylazinhydrochlorid -Lösung

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise
Alle Fotos(1)

About This Item

CAS-Nummer:
61763-23-3
MDL-Nummer:
MFCD00798875
UNSPSC-Code:
12352116
PubChem Substanz-ID:
329817143
NACRES:
NA.77

Form

aqueous solution

Qualitätsniveau

200

Arzneimittelkontrolle

USDEA Schedule III; stupéfiant (France); regulated under CDSA - not available from Sigma-Aldrich Canada; psicótropo (Spain)

Lagertemp.

2-8°C

SMILES String

Cl.Cl.Cc1cccc(C)c1NC2=NCCCS2.CNC3(CCCCC3=O)c4ccccc4Cl

InChI

1S/C13H16ClNO.C12H16N2S.2ClH/c1-15-13(9-5-4-8-12(13)16)10-6-2-3-7-11(10)14;1-9-5-3-6-10(2)11(9)14-12-13-7-4-8-15-12;;/h2-3,6-7,15H,4-5,8-9H2,1H3;3,5-6H,4,7-8H2,1-2H3,(H,13,14);2*1H

InChIKey

IYJHJWJNWIPQFJ-UHFFFAOYSA-N

Suchen Sie nach ähnlichen Produkten? Aufrufen Leitfaden zum Produktvergleich

Biochem./physiol. Wirkung

This is a solution of ketamine hydrochloride, an NMDA receptor antagonist, and xylazine hydrochloride, an α2- adrenergic receptor agonist.

Sonstige Hinweise

Dieses Produkt kann nicht telefonisch bestellt werden.

Nur Kit-Komponenten

Produkt-Nr.
Beschreibung
  • Ketamine hydrochloride 80 mg/mL
  • Xylazine hydrochloride 6 mg/mL

Lagerklassenschlüssel

10 - Combustible liquids

WGK

WGK 3

Flammpunkt (°F)

Not applicable

Flammpunkt (°C)

Not applicable

Persönliche Schutzausrüstung

Eyeshields, Faceshields, Gloves, type ABEK (EN14387) respirator filter

Analysenzertifikate (COA)

Suchen Sie nach Analysenzertifikate (COA), indem Sie die Lot-/Chargennummer des Produkts eingeben. Lot- und Chargennummern sind auf dem Produktetikett hinter den Wörtern ‘Lot’ oder ‘Batch’ (Lot oder Charge) zu finden.

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Kunden haben sich ebenfalls angesehen

Slide 1 of 5

1 of 5

Ketamin -hydrochlorid European Pharmacopoeia (EP) Reference Standard

Y0000450

Ketamin -hydrochlorid

USP

USP

1720407

Xylazin

Ketamin-D4 -hydrochlorid -Lösung 100 μg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®

Supelco

K-003

Ketamin-D4 -hydrochlorid -Lösung

Ketamin-D4 -hydrochlorid -Lösung 1.0 mg/mL in methanol (as free base), certified reference material, Cerilliant®

Supelco

K-006

Ketamin-D4 -hydrochlorid -Lösung

Buprenorphin -hydrochlorid -Lösung analytical standard, for drug analysis

Supelco

B7536

Buprenorphin -hydrochlorid -Lösung

Maosong Xie et al.
Arquivos brasileiros de oftalmologia, 81(3), 188-194 (2018-06-21)
To evaluate the efficacy of prostaglandin antagonists on blood-retinal barrier breakdown induced by anterior segment intraocular simulated surgery. Rats were randomly assigned to a negative control group, model group, nonsteroidal anti-inflammatory drugs prophylactic treatment group, nonsteroidal anti-inflammatory drugs treatment group
Yibin Kang
Methods in molecular biology (Clifton, N.J.), 568, 7-19 (2009-07-08)
Metastatic spread of cancer cells from the primary tumors to distant vital organs, such as lung, liver, brain, and bone, is responsible for the majority of cancer-related deaths. Cancer stem cells are likely to play essential roles in the metastatic
Mao-Song Xie et al.
Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde, 222(1), 42-47 (2007-12-22)
To develop a practical rat model of blood-retinal barrier (BRB) breakdown induced by anterior segment intraocular surgery. A 27-gauge needle attached to infusion tubing running to a bottle of balanced salt solution was inserted through the limbus into the rat
Mao-Song Xie et al.
International journal of ophthalmology, 10(12), 1824-1829 (2017-12-21)
To clarify the mechanism of infliximab treatment in diabetic macular edema (DME) and to provide a new alternative therapy for DME. Rats were randomly divided into the control group, the model group and the infliximab treatment group. A diabetic rat
Maosong Xie et al.
Arquivos brasileiros de oftalmologia, 81(3), 188-194 (2018-06-21)
To evaluate the efficacy of prostaglandin antagonists on blood-retinal barrier breakdown induced by anterior segment intraocular simulated surgery. Rats were randomly assigned to a negative control group, model group, nonsteroidal anti-inflammatory drugs prophylactic treatment group, nonsteroidal anti-inflammatory drugs treatment group
Alle zugehörigen Dokumente anzeigen

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.